Last Posted: Jun 16, 2020
- Association of MICA gene polymorphisms with thionamide-induced agranulocytosis.
Ma P, et al. Journal of endocrinological investigation 2020 6
- An intronic HCP5 variant is associated with age of onset and susceptibility to Graves' disease in UK and Polish cohorts.
Lane Laura Claire, et al. The Journal of clinical endocrinology and metabolism 2020 6
- Gene polymorphisms of pro-inflammatory cytokines may affect the risk of Graves' disease: a meta-analysis.
Zhu P, et al. Journal of endocrinological investigation 2020 5
- Polymorphisms of the genes CTLA4, PTPN22, CD40, and PPARG and their roles in Graves' disease: susceptibility and clinical features.
Bufalo Natássia Elena, et al. Endocrine 2020 5
- Candidate gene associations reveal sex-specific Graves' disease risk alleles among Chinese Han populations.
Yan Chen-Yan, et al. Molecular genetics & genomic medicine 2020 4 e1249
- Genetic study in a large cohort supported different pathogenesis of Graves' diseases and Hashimoto's hypothyroidism.
Zhang Qian-Yue, et al. The Journal of clinical endocrinology and metabolism 2020 4
- Gene polymorphisms of VEGF and VEGFR2 are associated with the severity of Hashimoto's disease and the intractability of Graves' disease, respectively.
Okamoto Mami, et al. Endocrine journal 2020 2
- Elevated phosphatidylserine-specific phospholipase A1 level in hyperthyroidism.
Nakawatari Kazuki, et al. Clinica chimica acta; international journal of clinical chemistry 2020 1 99-106
- Association of cytokine Th2 gene polymorphisms with autoimmune thyroid diseases in Tunisian population.
Mestiri Souhir, et al. International journal of immunogenetics 2020 1
- Increases of CD80 and CD86 Expression on Peripheral Blood Cells and their Gene Polymorphisms in Autoimmune Thyroid Disease.
Watanabe Ayano, et al. Immunological investigations 2019 11 1-13
- The interferon-induced helicase C domain-containing protein 1 gene variant (rs1990760) as an autoimmune-based pathology susceptibility factor.
Wawrusiewicz-Kurylonek Natalia, et al. Immunobiology 2019 11
- A significant association of the CTLA4 gene variants with the risk of autoimmune Graves' disease in ethnic Kashmiri population.
Shehjar Faheem, et al. Cellular immunology 2019 10 103995
- Progress in pediatrics in 2015: choices in allergy, endocrinology, gastroenterology, genetics, haematology, infectious diseases, neonatology, nephrology, neurology, nutrition, oncology and pulmonology.
Caffarelli Carlo et al. Italian journal of pediatrics 2016 Aug 42(1) 75
- Fine mapping of thyroglobulin gene identifies two independent risk loci for Graves' disease in Chinese Han population.
Xuan Miao, et al. Annals of translational medicine 2019 9 (18) 434
- Investigation of the Correlation between Graves' Ophthalmopathy and CTLA4 Gene Polymorphism.
Chen Ding-Ping, et al. Journal of clinical medicine 2019 11 (11)
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Quick Links to Other Resources
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.